Table of Contents

|Articles|December 1, 2003

Pharmaceutical Executive

Pharmaceutical Executive-12-01-2003

Table of Contents

External Link - article-78964.pdf

Articles in this issue

over 22 years ago

Article

Predicting Success: A Pipeline Report

over 22 years ago

Article

Interferons: A Family Business

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Articles in this issue

Related Content

What Kinds of Disruption are GLP-1s Expected to Face

Pharmaceutical Executive Daily: FDA Approves Datroway

FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates

Director of NIH Infectious Disease Institute Steps Down

The Biotech Industry’s Relationship with Real-Time Data: Q&A with Dr. Richard Graham

Trending on PharmExec

FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates

Eli Lilly Enters $202 Million Agreement to Acquire Engage Bio

Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report

Pharma Roundup: Bristol Myers Squibb Enters Strategic Agreement with Anthropic, Incyte and Genesis Expand Strategic Collaboration

Pharmaceutical Executive Daily: FDA Approves Datroway